Skip to main content
. 2022 Nov 10;12:1000146. doi: 10.3389/fonc.2022.1000146

Figure 3.

Figure 3

The comparisons of somatic mutation characteristics and signatures among colorectal cancer patients with different stages. (A) The bar plots comparing gene alteration rates in early- (Stage 0~II, N=62) and late-stage patients (Stage III~IV, N=71). (B) Forest plot of somatic mutation rates of stage III colorectal cancer patients with metastatic disease (T3N0, N=34) compared to patients without metastatic disease (T3NX, N=38). (C) The bar plots comparing somatic mutation signatures between patients with metastatic disease (T3N0, N=34) and patients without metastatic disease (T3NX, N=38). *p < 0.05.